Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Equity (2016 - 2026)

Angiodynamics' Return on Equity history spans 16 years, with the latest figure at 0.18% for Q1 2026.

  • For Q1 2026, Return on Equity rose 4.0% year-over-year to 0.18%; the TTM value through Feb 2026 reached 0.18%, up 4.0%, while the annual FY2025 figure was 0.17%, 46.0% up from the prior year.
  • Return on Equity reached 0.18% in Q1 2026 per ANGO's latest filing, down from 0.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.02% in Q3 2023 to a low of 1.21% in Q3 2024.
  • Average Return on Equity over 5 years is 0.31%, with a median of 0.16% recorded in 2025.
  • Peak YoY movement for Return on Equity: crashed -122bps in 2024, then soared 103bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.08% in 2022, then soared by 57bps to 0.03% in 2023, then tumbled by -3343bps to 1.17% in 2024, then soared by 87bps to 0.16% in 2025, then fell by -15bps to 0.18% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Return on Equity are 0.18% (Q1 2026), 0.16% (Q4 2025), and 0.18% (Q3 2025).